DiscoverThe Lancet Digital Health in conversation withPredicting the added benefit of adjuvant chemotherapy
Predicting the added benefit of adjuvant chemotherapy

Predicting the added benefit of adjuvant chemotherapy

Update: 2020-02-19
Share

Description

Prof Anant Madabhushi and Dr Samuel talk about the utility of a radiomic risk score applied to CT scans of patients with early stage non-small cell lung carcinoma.

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Comments 
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Predicting the added benefit of adjuvant chemotherapy

Predicting the added benefit of adjuvant chemotherapy

The Lancet